Right of audience, The Danish Supreme Court 1990
Admission to practice law 1985
Master of Laws 1982
English, Norwegian, Swedish
Jacob Hjortshøj is an expert in M&A transactions, company law, stock exchange law and public offers. He has extensive experience in business transfers and private equity, and he has advised an impressive number of Danish and international corporates, private equity funds and investment banks on M&A transactions.
Over the past few years Jacob Hjortshøj has acted as team-leader in an impressive number of trans-actions in respect of companies such as SFK LeBlanc, Lakrids by Johan Bülow, Ferrosan Medical De-vices, Hoyer Motors, FC Nordsjaelland, Bluegarden, Cembrit, Norican, Sonion, Euro Cater, Dagrofa, MissionPharma, Bladt Industries, NKT Flexibles, inco Danmark, Dyrup, Glud & Marstrand, Aalborg Industries, Superfos, KMD, Kommunekemi, Rosti, Codan Gummi, Stryhn’s, BabySam, Logstor, Disa, Unifeeder, Tholstrup Cheese, NEG Micon – Vestas fusion and Roulunds.
Jacob has always valued professionalism highly and is the chairman of the advisory group on corporate law under the Association of Danish Law Firms and the secretary of the Danish Association for Company Law.
Furthermore, he has also worked as an external lecturer in Company Law at the University of Copenhagen for ten years and is a regular teacher in the auspices of Danish Bar and Law Society.
Jacob is top ranked by all major ranking firms within Mergers & Acquisitions and Company Law.
IFLR1000 Rating 2016
- Mergers and acquisitions
It is on the M&A side that the firm perhaps shines the brightest, consistently coming out as one of the most active firms in the region for new deals. One example of that this year saw Jens Christian Hesse Rasmussen lead the way as the firm advised BioAlliance Pharma, a French-listed company, on its cross-border merger with the Danish –listed Topotarget. The firm’s client continued as the operating company so the deal involved the delisting of Topotarget and secondary listing of the new entity, Onxeo, on the Copenhagen exchange.
Elsewhere, Jacob Hjortshøj led a team advising Altor Fund III on the sale of the Sonion Group to Novo, a deal involving interests in seven different countries around the world: Denmark, Poland, the Netherlands, USA, China, Vietnam and the Philippines.
IFLR1000, Mergers and acquisitions